Skip to main content
Premium Trial:

Request an Annual Quote

At Least We Know Open Access Was a Hit

Bloggers are abuzz about the ScienceOnline'09 conference held in North Carolina. Alice Pawley at ScienceWomen has her first post liveblogging some of the event, focusing on a session about open access. She goes through basic definitions of different OA levels, as well as benefits of the model for scientists.

Meanwhile, James Hrynyshyn at Island of Doubt says the best part of the meeting for him was getting acquainted with new blogs, and at this post he lists his favorites.

And at Science in the Open, Cameron Neylon discusses how using a standard such as OpenID might improve citation rates. "The issue of unique researcher identifiers has really emerged as absolutely central to making traditional publication work better," he writes. "Good citation practice lies at the core of good science. ... How then is it that we have no way of citing a person?"

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.